No Annulment of Arbitral Award in Patent License Dispute as contrary to Art.101 TFEU: Genentech, Inc. v Hoechst GmbH / Sanofi-Aventis GmbH
…under German law to Genentech for the use of a human cytomegalovirus (HMCV) enhancer. The technology was the subject of two U.S. patents and one European Patent. A running royalty…